Author Index
Search or browse for an author across our entire electronic archive
Search results for: K
Results 171 - 180 of 1824 shown below
Kameyama, T
Y Suefuji, T Sasatomi, S Shichijo, S Nakagawa, H Deguchi, T Koga, T Kameyama and K Itoh
Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients
doi:10.1054/bjoc.2000.1690
Kamidono, S
H Miyake, I Hara, K Yamanaka, K Gohji, S Arakawa and S Kamidono
Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells
doi:10.1038/sj.bjc.6690264
-
H Miyake, S Hara, S Arakawa, S Kamidono and I Hara
Optimal timing and dosage of chemotherapy as a combined treatment with androgen withdrawal in the human prostate LNCaP tumour model
doi:10.1054/bjoc.2000.1686
Kamijo, R
T Toyoshima, R Kamijo, K Takizawa, K Sumitani, D Ito and M Nagumo
Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21
doi:10.1038/sj.bjc.6600183
Abstract | Full article | PDF
-
K Takizawa, R Kamijo, D Ito, M Hatori, K Sumitani and M Nagumo
Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-
B independent pathwaydoi:10.1038/sj.bjc.6690449
Kamikawa, T
K Hata, T Kamikawa, S Arao, H Tashiro, H Katabuchi, H Okamura, R Fujiwaki, K Miyazaki and M Fukumoto
Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
doi:10.1038/sj.bjc.6690294
Kamimura, K
Y Mizukami, K Kono, Y Kawaguchi, H Akaike, K Kamimura, H Sugai and H Fujii
Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer
advance online publication, 2007-12-18 00:00:00.000;
doi:10.1038/sj.bjc.6604149
Abstract | Full article | PDF
-
Y Mizukami, K Kono, T Maruyama, M Watanabe, Y Kawaguchi, K Kamimura and H Fujii
Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma
advance online publication, 2008-10-07 00:00:00.000;
doi:10.1038/sj.bjc.6604715
Abstract | Full article | PDF
Kamimura, M
Y Takeda, E Tsuduki, S Izumi, M Hojo, M Kamimura, G Naka, K Kobayashi and K Kudo
A phase I/II trial of irinotecan–cisplatin combined with an anti-late-diarrhoeal programme to evaluate the safety and antitumour response of this combination therapy in patients with advanced non-small-cell lung cancer
advance online publication, 2005-11-15 00:00:00.000;
doi:10.1038/sj.bjc.6602866
Abstract | Full article | PDF
Kaminski, N
O Margalit, L Eisenbach, N Amariglio, N Kaminski, A Harmelin, R Pfeffer, M Shohat, G Rechavi and R Berger
Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines
doi:10.1038/sj.bjc.6600977
Abstract | Full article | PDF
Kaminski, R
J Golab, G Wilczynski, R Zagozdzon, T Stoklosa, A Dabrowska, J Rybczynska, M Wasik, E Machaj, T Oldak, K Kozar, R Kaminski, A Giermasz, A Czajka, W Lasek, W Feleszko and M Jakobisiak
Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF
doi:10.1054/bjoc.1999.1078
Kaminsky, M C
R Bugat, A Bataillard, T Lesimple, J J Voigt, S Culine, A Lortholary, Y Merrouche, G Ganem, M C Kaminsky, S Negrier, M Perol, C Laforêt, P Bedossa, G Bertrand, J M Coindre and K Fizazi
Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)
doi:10.1038/sj.bjc.6601085
Abstract | Full article | PDF
Kaminsky, M-C
C Massard, J-J Voigt, A Laplanche, S Culine, A Lortholary, R Bugat, C Theodore, F Priou, M-C Kaminsky, T Lesimple, X Pivot, B Coudert, J-Y Douillard, Y Merrouche and K Fizazi
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
advance online publication, 2007-09-18 00:00:00.000;
doi:10.1038/sj.bjc.6603942
Abstract | Full article | PDF
-
C Massard, J-J Voigt, A Laplanche, S Culine, A Lortholary, R Bugat, C Theodore, F Priou, M-C Kaminsky, T Lesimple, X Pivot, B Coudert, J-Y Douillard, Y Merrouche and K Fizazi
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
doi:10.1038/sj.bjc.6604800
Abstract | Full article | PDF
-
Result page:
- 1|
- 2|
- 3|
- 4|
- 5|
- 6|
- 7|
- 8|
- 9|
- 10|
- 11|
- 12|
- 13|
- 14|
- 15|
- 16|
- 17|
- 18|
- 19|
- 20|
- 21|
- 22|
- 23|
- 24|
- 25|
- 26|
- 27|
- 28|
- 29|
- 30|
- 31|
- 32|
- 33|
- 34|
- 35|
- 36|
- 37|
- 38|
- 39|
- 40|
- 41|
- 42|
- 43|
- 44|
- 45|
- 46|
- 47|
- 48|
- 49|
- 50|
- 51|
- 52|
- 53|
- 54|
- 55|
- 56|
- 57|
- 58|
- 59|
- 60|
- 61|
- 62|
- 63|
- 64|
- 65|
- 66|
- 67|
- 68|
- 69|
- 70|
- 71|
- 72|
- 73|
- 74|
- 75|
- 76|
- 77|
- 78|
- 79|
- 80|
- 81|
- 82|
- 83|
- 84|
- 85|
- 86|
- 87|
- 88|
- 89|
- 90|
- 91|
- 92|
- 93|
- 94|
- 95|
- 96|
- 97|
- 98|
- 99|
- 100|
- 101|
- 102|
- 103|
- 104|
- 105|
- 106|
- 107|
- 108|
- 109|
- 110|
- 111|
- 112|
- 113|
- 114|
- 115|
- 116|
- 117|
- 118|
- 119|
- 120|
- 121|
- 122|
- 123|
- 124|
- 125|
- 126|
- 127|
- 128|
- 129|
- 130|
- 131|
- 132|
- 133|
- 134|
- 135|
- 136|
- 137|
- 138|
- 139|
- 140|
- 141|
- 142|
- 143|
- 144|
- 145|
- 146|
- 147|
- 148|
- 149|
- 150|
- 151|
- 152|
- 153|
- 154|
- 155|
- 156|
- 157|
- 158|
- 159|
- 160|
- 161|
- 162|
- 163|
- 164|
- 165|
- 166|
- 167|
- 168|
- 169|
- 170|
- 171|
- 172|
- 173|
- 174|
- 175|
- 176|
- 177|
- 178|
- 179|
- 180|
- 181|
- 182|
- 183|
- Next
